Psyence Biomedical Ltd is a multi-asset, vertically integrated biopharmaceutical company specializing in psychedelic-based therapeutics. The Company is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. It is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.
Ticker SymbolPBM
CompanyPsyence Biomedical Ltd
CEOMaresky (Neil)
Website
FAQs
What is the current price of Psyence Biomedical Ltd (PBM)?
The current price of Psyence Biomedical Ltd (PBM) is 1.000.
What is the symbol of Psyence Biomedical Ltd?
The ticker symbol of Psyence Biomedical Ltd is PBM.
What is the 52-week high of Psyence Biomedical Ltd?
The 52-week high of Psyence Biomedical Ltd is 62.724.
What is the 52-week low of Psyence Biomedical Ltd?
The 52-week low of Psyence Biomedical Ltd is 1.410.
What is the market capitalization of Psyence Biomedical Ltd?
The market capitalization of Psyence Biomedical Ltd is 1.87M.
What is the net income of Psyence Biomedical Ltd?
The net income of Psyence Biomedical Ltd is 1.01M.
Is Psyence Biomedical Ltd (PBM) currently rated as Buy, Hold, or Sell?
According to analysts, Psyence Biomedical Ltd (PBM) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Psyence Biomedical Ltd (PBM)?
The Earnings Per Share (EPS TTM) of Psyence Biomedical Ltd (PBM) is -62.387.